Kelly A. Romano - Director at LeonaBio, Inc.

Insider Transactions and Holdings

Identity
Entity type
Individual
Issuer context
SEC evidence

There are no Buy or Sell transactions made by Kelly A. Romano since 30 May 2025

Holdings reported by Kelly A. Romano for LeonaBio, Inc.

Form 4 holding Director

Athira Pharma, Inc.

Security class
Common Stock
Shares / value
80,715
Estimated value
$194,951
Report date
24 Jun 2024
Price
$2.42
Ownership
Direct
Form 4 holding Director

LeonaBio, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
28,000
Estimated value
Report date
09 Apr 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transactions reported by Kelly A. Romano for LeonaBio, Inc.

Sym Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .